{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:28:19Z","timestamp":1781893699987,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jdiacomp.2022.108359","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T11:31:53Z","timestamp":1669289513000},"page":"108359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients"],"prefix":"10.1016","volume":"36","author":[{"given":"Emir","family":"Muzurovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredi","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri P.","family":"Mikhailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2022.108359_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108341","article-title":"Obesity, but not glycemic control, predicts liver steatosis in children with type 1 diabetes","volume":"36","author":"Tas","year":"2022","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0010","article-title":"Non-alcoholic fatty liver disease in children","author":"Muzurovi\u0107","year":"2022","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0015","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/apt.17096","article-title":"Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000\u20132021","volume":"56","author":"Li","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0020","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.2147\/DMSO.S223618","article-title":"Obesity in patients with type 1 diabetes: links, risks and management challenges","volume":"14","author":"Vilarrasa","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0025","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.2174\/1381612819666131206112537","article-title":"Managing the cardiovascular risk associated with the metabolic syndrome","volume":"20","author":"Montalto","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0030","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2021.10.013","article-title":"Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease","volume":"76","author":"Luukkonen","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0035","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jacl.2015.03.010","article-title":"Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease","volume":"9","author":"Sonmez","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0040","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/HYPERTENSIONAHA.122.17982","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease: a review of shared cardiometabolic risk factors","volume":"79","author":"Muzurovi\u0107","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk","volume":"119","author":"Muzurovi\u0107","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0050","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.1038\/s41598-022-14856-w","article-title":"Increased risk of pancreatic cancer in individuals with non-alcoholic fatty liver disease","volume":"12","author":"Park","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/met.2015.0018","article-title":"Insulin resistance but not visceral adiposity index is associated with liver fibrosis in nondiabetic subjects with nonalcoholic fatty liver disease","volume":"13","author":"Ercin","year":"2015","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s10620-021-06824-7","article-title":"Nonalcoholic fatty pancreas disease: role in metabolic syndrome, \"prediabetes,\" diabetes and atherosclerosis","volume":"67","author":"Filippatos","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/00033197211014676","article-title":"Perivascular adipose tissue: pathophysiological links with inflammation, atherosclerosis, and thrombosis","volume":"73","author":"Katsiki","year":"2022","journal-title":"Angiology"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/10742484211006997","article-title":"Can we decrease epicardial and pericardial fat in patients with Diabetes?","volume":"26","author":"Muzurovi\u0107","year":"2021","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/157016112001211228145754","article-title":"Epicardial adipocyte-derived TNF-\u03b1 modulates local inflammation in patients with advanced coronary artery disease","volume":"20","author":"Muzurovi\u0107","year":"2022","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0080","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/hep4.1818","article-title":"Risk of cardiovascular disease in individuals with nonobese nonalcoholic fatty liver disease","volume":"6","author":"Arvind","year":"2022","journal-title":"Hepatol Commun."},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0085","doi-asserted-by":"crossref","first-page":"116","DOI":"10.14309\/ajg.0000000000000845","article-title":"Effects of statin use on the development and progression of nonalcoholic fatty liver disease: a Nationwide nested case-control study","volume":"116","author":"Lee","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0090","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2174\/1570161118666201015152921","article-title":"Prevalence, diagnosis, and treatment with 3 different statins of non-alcoholic fatty liver Disease\/Non-alcoholic steatohepatitis in military personnel. Do genetics play a Role?","volume":"19","author":"Sfikas","year":"2021","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0095","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2174\/1570161118666201008162537","article-title":"Editorial on prevalence, diagnosis and treatment with 3 different statins of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis in military personnel. Do genetics play a role?","volume":"19","author":"Muzurovi\u0107","year":"2021","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0100","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/17474124.2018.1477588","article-title":"Statins in liver disease: not only prevention of cardiovascular events","volume":"12","author":"Magan-Fernandez","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0105","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1517\/14712598.2015.1067299","article-title":"Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study","volume":"15","author":"Rizvi","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107619","article-title":"Weight-centric pharmacological management of type 2 diabetes mellitus - an essential component of cardiovascular disease prevention","volume":"34","author":"Muzurovi\u0107","year":"2020","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0115","doi-asserted-by":"crossref","first-page":"100765","DOI":"10.1016\/j.aohep.2022.100765","article-title":"NAFLD VS MAFLD. The evidence-based debate has come. Time to change?","volume":"27","author":"Garc\u0131a-Compean","year":"2022","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jdiacomp.2022.108359_bb0120","first-page":"388","article-title":"Global multi-stakeholder consensus on the redefinition of fatty liver disease. Global multi-stakeholder endorsement of the MAFLD definition","volume":"7","author":"M\u00e9ndez-S\u00e1nchez","year":"2022","journal-title":"LancetGastroenterol Hepatol"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872722002719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872722002719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:16:32Z","timestamp":1761005792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872722002719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1056872722002719"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108359","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108359"}}